Form 4: H.B. Fuller CFO Corkrean Reports Equity Holdings
Insider Ownership Report
H.B. Fuller's Executive VP and CFO, John J. Corkrean, filed a Form 4 detailing his beneficial ownership of common stock, phantom units, and employee stock options.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller Co. (FUL), filed a Statement of Changes in Beneficial Ownership (Form 4).
- He directly beneficially owns 59,508 shares of Common Stock.
- On February 27, 2026, he acquired 191.78 Phantom Units, which convert into shares of common stock on a 1-for-1 basis.
- The total beneficially owned Phantom Units amount to 32,612, including units acquired pursuant to a dividend equivalent feature.
- He holds various Employee Stock Options (Right-to-Buy) with exercise prices ranging from $45.05 to $77.72 and expiration dates extending up to January 26, 2036.
- He also holds Restricted Stock Units (RSUs) totaling 1,453.86, 5,824.9, and 2,940.13 units, which convert to common stock on a 1-for-1 basis and vest in three annual installments. These RSU amounts include units acquired via a dividend equivalent reinvestment feature.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, typical for reporting executive compensation and beneficial ownership changes, with no immediate positive or negative implications for the company's operational performance or financial health.
Industry Context
StockSavvy.ai notes that routine Form 4 filings, such as this one detailing executive equity holdings and compensation, are standard disclosures in the U.S. market. They provide transparency into insider ownership but typically do not reflect broader industry trends or competitive positioning.
Related Party Transactions
- The acquisition of Phantom Units and Restricted Stock Units are part of the executive's compensation plan, representing equity-based awards from the company.
Stakeholder Impact
- Shareholders: Provides transparency regarding executive equity ownership and compensation structure, aligning management interests with shareholder value.
- Employees: Reflects standard executive compensation practices, which may influence broader compensation strategies within the company.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Grant date for 100% vested Employee Stock Option (Right-to-Buy) with an exercise price of $50.1. |
| 01/25/2019 | Grant date for 100% vested Employee Stock Option (Right-to-Buy) with an exercise price of $53.57. |
| 01/24/2020 | Grant date for 100% vested Employee Stock Option (Right-to-Buy) with an exercise price of $45.05. |
| 01/24/2021 | Grant date for 100% vested Employee Stock Option (Right-to-Buy) with an exercise price of $48.35. |
| 01/27/2022 | Grant date for 100% vested Employee Stock Option (Right-to-Buy) with an exercise price of $51.89. |
| 01/24/2023 | Grant date for 100% vested Employee Stock Option (Right-to-Buy) with an exercise price of $72.94. |
| 01/24/2024 | Grant date for 100% vested Employee Stock Option (Right-to-Buy) with an exercise price of $68.17. |
| 01/26/2025 | Vesting start date for an Employee Stock Option (Right-to-Buy) with an exercise price of $77.72, vesting in three annual installments. |
| 01/26/2025 | Vesting start date for 1,453.86 Restricted Stock Units, vesting in three annual installments. |
| 01/26/2025 | Vesting start date for 5,824.9 Restricted Stock Units, vesting in three annual installments. |
| 01/27/2026 | Vesting start date for an Employee Stock Option (Right-to-Buy) with an exercise price of $64.28, vesting in three annual installments. |
| 01/27/2026 | Vesting start date for 2,940.13 Restricted Stock Units, vesting in three annual installments. |
| 02/27/2026 | Transaction date for the acquisition of 191.78 Phantom Units. |
| 01/26/2027 | Vesting start date for an Employee Stock Option (Right-to-Buy) with an exercise price of $59.81, vesting in three annual installments. |
| 01/26/2027 | Expiration date for 1,453.86 Restricted Stock Units. |
| 01/27/2028 | Expiration date for 2,940.13 Restricted Stock Units. |
| 01/25/2028 | Expiration date for Employee Stock Option (Right-to-Buy) granted 01/25/2019. |
| 01/26/2029 | Expiration date for 5,824.9 Restricted Stock Units. |
| 01/24/2029 | Expiration date for Employee Stock Option (Right-to-Buy) granted 01/24/2020. |
| 01/24/2030 | Expiration date for Employee Stock Option (Right-to-Buy) granted 01/24/2021. |
| 01/27/2031 | Expiration date for Employee Stock Option (Right-to-Buy) granted 01/27/2022. |
| 01/24/2032 | Expiration date for Employee Stock Option (Right-to-Buy) granted 01/24/2023. |
| 01/24/2033 | Expiration date for Employee Stock Option (Right-to-Buy) granted 01/24/2024. |
| 01/26/2034 | Expiration date for Employee Stock Option (Right-to-Buy) granted 01/26/2025. |
| 01/27/2035 | Expiration date for Employee Stock Option (Right-to-Buy) granted 01/27/2026. |
| 01/26/2036 | Expiration date for Employee Stock Option (Right-to-Buy) granted 01/26/2027. |
Recommendation
holdThis Form 4 filing is a routine disclosure of an executive's beneficial ownership and compensation-related equity grants. It does not contain information that would fundamentally alter the investment thesis for H.B. Fuller Co. Therefore, a 'hold' recommendation is appropriate as it provides transparency but no new material information to warrant a change in investment stance.
Keywords
H.B. Fuller Co., FUL, Form 4, Insider Trading, Beneficial Ownership, Executive Compensation, Stock Options, Restricted Stock Units, Phantom Units, John J. Corkrean
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.